DSO Offer Red Flags to Resolve Before You Commit

Treat DSO offer red flags as decisions about commitment

A DSO offer red flag matters when it could change what the seller agrees to, shares, spends, or does next. Start with that next action. A request to clarify a missing term differs from a request to sign a restriction, start a system change, or rely on future equity proceeds.

Write the concern as a specific sentence. For example, the buyer asks the seller to approve a conversion expense before funding has been confirmed. That description is more useful than saying the offer feels aggressive. It identifies both the proposed commitment and the evidence the seller lacks.

This guide screens the seller's exposure during negotiation. The DSO versus private buyer comparison addresses overall fit and value. The buyer red-flags guide investigates defects in the practice being purchased. Here, the subject is whether the proposed relationship and next commitment remain acceptable to the seller.

Find the person and document behind each promise

Ask who is making the offer, who can approve a change, who would owe payment, and who would employ the seller. Request an explanation when those are different entities. A brand name on a presentation does not answer every one of those questions.

The ADA's January 21, 2021 guide connects business service, employment, and other related terms. Review their interaction; an attractive acquisition proposal does not settle the ongoing relationship. ADA: DSO business services guide

Build a promise-to-document map. If the buyer promises local discretion over a decision, ask where that promise appears and which related document may limit it. If someone promises support, ask which entity provides it and how an unresolved request moves to a person with authority.

These requests do not imply that a different entity structure or an open term is improper. They establish what the seller needs to assess. Counsel should interpret obligations and remedies. The seller should decide commercial limits with the facts in view.

Separate a drafting gap from a condition you cannot accept

A missing answer may be curable. State the exact information needed and who can supply it. A direct conflict with a firm seller requirement needs a different discussion. If the seller cannot work the proposed schedule, clearer drafting of that schedule will not solve the problem.

Use an escalation path that matches the issue. Ask the deal lead to clarify an incomplete business answer. Take contract effects to counsel, investment risks to qualified investment and legal advisers, and treatment concerns to the qualified clinical lead. Do not let a commercial score overrule a professional duty.

The table is a commercial review framework, not a list of contractual rights. An owner may already have duties to act, give notice, or pay. Pausing an optional new commitment does not authorize ignoring existing obligations. Have counsel identify the actual choices before announcing withdrawal or stopping required work.

Escalate requests that move control ahead of the deal

Watch for a request to change the practice's operations for the buyer before the parties have established the proper authority and terms. Ask why the action must occur now, who directs it, who pays, and what happens if the deal does not close. Planning a change and implementing it are different actions.

The FTC's March 20, 2018 premerger guidance warns about inappropriate sensitive information sharing and premature coordination. Its discussion is particularly relevant to competitors or potential competitors. Counsel must assess the actual transaction; the dated article is not a complete current-law review. FTC: Premerger information safeguards

Bring counsel the request itself, including who would receive data or direct staff. Do not reframe a broad request as harmless support without checking it. The buyer may have a legitimate planning need that can be met through a narrower, properly controlled process.

Keep early outreach seller-blind and obtain an NDA before identifying the practice to a buyer. Time staff involvement around the work and duties they actually need to perform. Patient access, required notices, and clinical authority require their own review; neither an NDA nor a concern about the offer supplies blanket permission to share charts. Use the confidentiality guide to coordinate commercial disclosure.

Ask whether an investment claim is being presented as certainty

An illustration of a future payout is not evidence that the seller can realize it. Ask which actual security the seller would hold and which events would make cash available. Identify what remains outside the seller's control. Keep the proposed investment separate from the money available at closing.

The SEC staff's August 17, 2022 private-placement bulletin describes loss, illiquidity, and limited disclosure risks. It also states that a Form D filing is not SEC approval. Apply those cautions to an actual proposed private investment with advisers. SEC: Private-placement investor bulletin

The rolled equity guide covers issuer rights and payout mechanics in depth. For screening, ask whether the seller is being asked to accept exposure without enough information to evaluate it. A missing document can be requested; a refusal to supply essential information may leave no acceptable basis for proceeding.

Avoid treating one impressive prior exit as proof of a future result. Ask what is comparable and what changed. Also avoid treating uncertainty itself as evidence of wrongdoing. The practical issue is whether the seller understands and accepts the supported risks, including a result below the illustration.

Keep clinical concerns outside the price bargain

If a proposed operating plan appears to pressure inappropriate care, escalate the specific instruction promptly. Do not translate a patient-care concern into a requested price increase. Ask the qualified clinical and legal reviewers to assess what is proposed, who would direct it, and which duties apply.

ADA ethics supports patient involvement and confidentiality. It does not establish national DSO law. ADA: Patient autonomy

Distinguish a business goal from a clinical instruction. The fact that a buyer measures results does not alone prove improper care. Equally, a broad assurance of autonomy does not resolve a conflicting instruction. Preserve the actual wording and seek the review needed to protect patients and professional judgment.

If the seller will remain at work, compare the proposed role with the seller work-back guide. A seller's willingness to help does not establish a supported schedule, appropriate delegation, or a lawful employment arrangement. Those issues need their own evidence.

Calculate a fictional preclosing exposure limit

Assume a fictional seller sets a $30,000 ceiling for the nonrecoverable costs in a defined sale-review budget. This is a personal planning limit, not a market fee, legal materiality threshold, or recommended budget. The seller asks the team to seek a fresh decision before an optional new commitment would take the total above that ceiling.

Assume $8,000 has already been paid for completed advisory work. Another $12,000 is committed under a noncancelable engagement but remains unpaid. The seller is then asked to authorize an optional $18,000 system-conversion project before closing. For this base case, all three costs are assumed nonrefundable, distinct, and within the defined budget.

The current exposure is $20,000, leaving $10,000 under the seller's ceiling. Authorizing the full project would raise exposure to $38,000, which exceeds the ceiling by $8,000. Only $8,000 has been paid at the starting point, but treating that as the entire exposure would omit the existing $12,000 commitment.

Under the seller's invented rule, the optional conversion returns for a decision before authorization. The seller could discuss scope, timing, cost sharing, or whether to proceed at all. The model grants no right to cancel an engagement, recover fees, or require the buyer to pay them.

The budget excludes taxes, purchase adjustments, clinical obligations, damages, financing costs, and other unlisted items. It is not a complete measure of the seller's possible loss if the deal fails. Its purpose is to reveal a proposed commitment that a simple cash-paid total would miss.

Test refund terms and budget tolerance separately

First change only the conversion terms. Assume a reviewed agreement makes $12,000 of the $18,000 project payment refundable if a precisely defined stop event occurs. For this teaching branch, assume the event occurs and the full refund is received. The project's nonrecoverable portion is then $6,000. Combined exposure is $26,000, leaving $4,000 below the original $30,000 ceiling.

The gross paid or committed amount is still $38,000 before recovery. A future refund is not cash already in the bank. If it depends on a disputed event or an unwilling payer, the seller must assess that separately. The branch does not tell the seller to credit an unverified promise as a collected refund.

For a second independent sensitivity, return to the fully nonrefundable base case and reduce the seller's chosen ceiling to $24,000. The current $20,000 exposure leaves $4,000 of room. The proposed $38,000 total exceeds the new ceiling by $14,000. This changes tolerance, not the buyer's conduct or the agreement's refund terms.

Neither a result below the ceiling nor a lower proposed cost clears unresolved clinical, legal, privacy, or investment concerns. The calculations inform one spending decision. They should sit beside the issue log, not replace the professional review or the seller's broader exit plan.

Decide what would make the next step acceptable

Write a short instruction for each material concern: do not authorize the specified optional action until the named evidence has been reviewed by the responsible person. Keep the instruction precise. A broad command to stop everything may interrupt work the practice still needs to perform.

For a price or role disagreement, state what the seller would consider changing. For an evidence gap, state what would answer it. If the buyer supplies the evidence, reassess the concern rather than leaving a permanent red label attached to the organization. If a firm requirement remains incompatible, discuss an orderly end to talks with counsel.

Use the LOI guide to review actual restrictions and the next stage of diligence. Keep copies of prior documents and the latest marked changes. A reassuring call does not by itself change a signed obligation or settle a conflict between documents.

Common mistakes when screening a DSO offer

One mistake is using a high purchase price to offset an unresolved authority or care concern. Money may address an economic issue; it cannot supply a missing professional judgment. Keep those decisions separate in the seller's review.

Another mistake is counting only money already paid. The fictional case shows why a noncancelable unpaid commitment matters to the next spending decision. Ask counsel and the accountant to identify what the seller has actually committed and what remains optional.

Do not label every unanswered question a refusal. Give the responsible person a clear request and an agreed response point. But do not call an issue resolved because someone promises to answer it later. Preserve the remaining gap in the decision record.

Finally, avoid proceeding merely because the seller has invested time and money. Past spending does not improve the next commitment's terms. Reassess the choice using the current evidence, the seller's limits, and the obligations that already apply.

Summary: resolve the concern before adding the commitment

A useful DSO offer screen connects each concern to the action it would change. Ask for the right evidence, identify who can decide, and track paid costs separately from commitments and possible recoveries. Reconsider concerns when support changes, while keeping clinical and legal duties outside a price tradeoff. To review the commercial questions in a proposal with Jason Taken, business broker at HedgeStone Business Advisors, book a confidential intro call.